Outcomes of Patients Receiving Temporary Circulatory Support Before Durable Ventricular Assist Device

Annals of Thoracic Surgery

Volumn 103, Issue 1, 2017, Pages 106-112

  Shah, Palak ^a   Pagani, Francis D ^b   Desai, Shashank S ^a   Rongione, Anthony J ^a   Maltais, Simon ^c   Haglund, Nicholas A ^c   Dunlay, Shannon M ^d   Aaronson, Keith D ^b   Stulak, John M ^d   Davis, Mary Beth ^c   Salerno, Christopher T ^e   Cowger, Jennifer A ^e  

^a INOVA HEART AND VASCULAR INSTITUTE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d Mayo Clinic   (United States)

^e St Vincent Heart Center of Indiana   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CREATININE;

ADULT; ASSISTED CIRCULATION; CARDIOGENIC SHOCK; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CLINICAL OUTCOME; CONFERENCE PAPER; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; CONTROLLED STUDY; EXTRACORPOREAL OXYGENATION; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART OUTPUT; HEART RIGHT ATRIUM PRESSURE; HEART RIGHT VENTRICLE FAILURE; HEMODYNAMICS; HIGH RISK PATIENT; HUMAN; INFECTION; KIDNEY FAILURE; LEFT VENTRICULAR ASSIST DEVICE; LIVER FUNCTION; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORBIDITY; MORTALITY RISK; MULTIPLE ORGAN FAILURE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RIGHT VENTRICULAR ASSIST DEVICE; STATISTICAL ANALYSIS; SURVIVAL TIME; THROMBOSIS; CLINICAL TRIAL; COMPLICATION; FOLLOW UP; HEART ASSIST DEVICE; HEART FAILURE; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTOPERATIVE COMPLICATIONS; PROCEDURES; SHOCK, CARDIOGENIC; SURVIVAL RATE; TIME FACTOR; TREATMENT OUTCOME; TRENDS; UNITED STATES;

EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART-ASSIST DEVICES; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; MORBIDITY; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SHOCK, CARDIOGENIC; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84994476118     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2016.06.002     Document Type: Conference Paper

References (13)

1. 1 Kirklin, J.K., Naftel, D.C., Pagani, F.D., et al. Sixth INTERMACS annual report: a 10,000-patient database. J Heart Lung Transplant 33 (2014), 555–564.
2. 2 Stretch, R., Sauer, C.M., Yuh, D.D., Bonde, P., National trends in the utilization of short-term mechanical circulatory support: incidence, outcomes, and cost analysis. J Am Coll Cardiol 64 (2014), 1407–1415.
3. 3 Stevenson, L.W., Pagani, F.D., Young, J.B., et al. INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant 28 (2009), 535–541.
4. 4 Breslow, N., Covariance analysis of censored survival data. Biometrics 30 (1974), 89–99.
5. 5 Boyle, A.J., Ascheim, D.D., Russo, M.J., et al. Clinical outcomes for continuous-flow left ventricular assist device patients stratified by preoperative INTERMACS classification. J Heart Lung Transplant 30 (2011), 402–407.
6. 6 Shah, P., Smith, S., Haft, J.W., et al. Clinical outcomes of advanced heart failure patients with cardiogenic shock treated with temporary circulatory support before durable LVAD implant. ASAIO J 62 (2016), 20–27.
7. 7 Lietz, K., Long, J.W., Kfoury, A.G., et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation 116 (2007), 497–505.
8. 8 Cowger, J., Sundareswaran, K., Rogers, J.G., et al. Predicting survival in patients receiving continuous flow left ventricular assist devices: the HeartMate II risk score. J Am Coll Cardiol 61 (2013), 313–321.
9. 9 Matthews, J.C., Koelling, T.M., Pagani, F.D., Aaronson, K.D., The right ventricular failure risk score. A preoperative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol 51 (2008), 2163–2172.
10. 10 Durinka, J.B., Bogar, L.J., Hirose, H., et al. End-organ recovery is key to success for extracorporeal membrane oxygenation as a bridge to implantable left ventricular assist device. ASAIO J 60 (2014), 189–192.
11. 11 Rihal, C.S., Naidu, S.S., Givertz, M.M., et al. 2015 SCAI/ACC/HFSA/STS clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care. J Am Coll Cardiol 65 (2015), e7–e26.
12. 12 Thiele, H., Zeymer, U., Neumann, F.J., et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 367 (2012), 1287–1296.
13. 13 Sjauw, K.D., Engstrom, A.E., Vis, M.M., et al. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines?. Eur Heart J 30 (2009), 459–468.